Trinity Biotech plc to Announce Q1 2024 Financial Results

Group 1 - Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors [3] - The company will report its financial results for the first quarter of 2024 on May 23, 2024, at 8:30 AM ET [1] - Trinity Biotech has recently entered the wearable biosensor industry through the acquisition of biosensor assets from Waveform Technologies Inc., aiming to develop a range of biosensor devices starting with a continuous glucose monitoring product [3] Group 2 - The company's diagnostic systems include reagents and instrumentation for point-of-care and clinical laboratory segments, used to detect infectious diseases and quantify Haemoglobin A1c levels [3] - Trinity Biotech sells its products directly in the United States, Germany, France, and the U.K., and through a network of international distributors and strategic partners in over 75 countries worldwide [3]